https://www.thebodypro.com/tag/research

Research

The Latest

pulling back curtain

This Week in HIV Research: Life in the Integrase Era

Aug. 6, 2020: Recent trends in drug interaction rates; integrase inhibitors and cardiac event risk; a deep dive into HIV drug resistance in Florida; frailty symptoms and neurocognitive disorders amidst high CD4 counts.

By Barbara Jungwirth and Myles Helfand
Ricardo Diaz

Researcher Behind "Brazil Patient," the Latest HIV Remission Case, Explains How It Happened

The international news story that broke at AIDS 2020, explained by the lead researcher.

By Terri Wilder, M.S.W.
COVID-19 patient care-iStock-1218539192

Can Drugs That Cure Hepatitis C Treat COVID-19? Here’s the State of the Research So Far.

An interview with Andrew Hill, Ph.D., about his research presented at AIDS 2020.

By Terri Wilder, M.S.W.
solving maze

This Week in HIV Research: Solving the Riddle of Poor PrEP Uptake

July 30, 2020: HIV prevention shortfalls among adolescents of color; PrEP use among trans people; PrEP information gaps among women of color; the case for vacation-based (a.k.a. episodic) PrEP.

By Barbara Jungwirth and Myles Helfand
injectable

What Are the New HIV Treatment and Prevention Drugs Under Development in 2020?

Richard Jefferys of Treatment Action Group discusses the pipeline for new modalities being explored for treatment, PrEP, vaccine, and cure.

By Terri Wilder, M.S.W.
mental connection

This Week in HIV Research: The Mind Matters

July 23, 2020: Depression and HIV risk mitigation among MSM; a consistent HIV provider is good for CD4 and viral load; spirituality and HIV prevention; HCV treatment access and reinfection risk.

By Barbara Jungwirth and Myles Helfand
links in chain

This Week in HIV Research: Links in a Chain

July 16, 2020: Starting HIV treatment during hospitalization for people who use drugs; type of substance use affects viral suppression odds; benefits of a cross-disciplinary medical support team; does STI recency dictate PrEP necessity for women?

By Barbara Jungwirth and Myles Helfand
Ricardo Diaz, M.D. (top left) shares findings regarding a potential new HIV remission case in a virtual press conference during the 23rd International AIDS Conference on July 7, 2020.

HIV Clinical Research Highlights From AIDS 2020, the 23rd International AIDS Conference

COVID-19 or no, there was still plenty to learn at this year's virtual conference, including for U.S. clinicians seeking to improve the care and treatment they provide to their patients living with HIV.

By Myles Helfand
COVID-19 hospitalization

Still No Clear Indication That HIV Status Affects COVID-19 Severity

A pair of presentations at AIDS 2020 provides some of the largest studies to date on COVID-19 among people with HIV, but leaves us with many questions about the interplay between the two viruses.

By Myles Helfand
long road ahead

This Week in HIV Research: Do As We Say, Not As We Do

July 9, 2020: Abysmal HIV testing rates in U.S. ambulatory care settings; STI testing frequency in PrEP users; trends in U.S. PrEP uptake; integrating opioid therapy with HCV care in people who inject drugs.

By Barbara Jungwirth and Myles Helfand